Loading BMYMP…
Loading profile data…Frequently asked questions about BMYMP
What does Bristol-Myers Squibb Company PFD CONV 2 (BMYMP) do?
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales
Where does BMYMP trade?
Bristol-Myers Squibb Company PFD CONV 2 (BMYMP) trades on the Other OTC.
What sector is BMYMP in?
Bristol-Myers Squibb Company PFD CONV 2 (BMYMP) operates in the Healthcare sector, specifically in the Drug Manufacturers - General industry.
Who is the CEO of Bristol-Myers Squibb Company PFD CONV 2?
Christopher S. Boerner is the chief executive officer of Bristol-Myers Squibb Company PFD CONV 2 (BMYMP).
Where is Bristol-Myers Squibb Company PFD CONV 2 headquartered?
Bristol-Myers Squibb Company PFD CONV 2 is headquartered in United States.
When did BMYMP go public?
Bristol-Myers Squibb Company PFD CONV 2 (BMYMP) completed its initial public offering in 2003.